Whipple’s syndrome: literature review and case report

1. la Scola B., Fenollar F., Fournier P-E. et al. Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple’s disease bacillus // International Journal of Systematic and Evolutionary Microbiology. 2001. Vol. 51(4). P. 1471–1479. 2. Whipple G.H. A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues // Bulletin of the Johns Hopkins Hospital. 1907. Vol. 18. Р. 382–393. 3. Durand D.V., Lectomte C., Cathebras P. et al. Whipple disease. Clinical review of 52 cases. The SNFMI research group on Whipple disease // Societe Nationale Francaise de Medecine Interne. 1997. Vol. 76. P. 170. 4. Schneider T., Moos V., Loddenkemper C. et al. Whipple’s Disease: new aspects of pathogenesis and treatment // Lancet. Infect. Dis. 2008. Vol. 8. P. 179–190. 5. Fennollar F., Lepidi H., Raoult D. Whipple’s endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis // Clin Infect Dis. 2001. Vol. 33. P. 1309. 6. Biagi F, Balduzzi D., Delvino P. et al. Prevalence of Whipple’s disease in north-western Italy // Eur J Clin Microbiol Infect Dis. 2015. Vol. 34. P. 347–1348. 7. Von Herbay A., Otto H.F., Stolte M. et al. Epidemiology of Whipple’s disease in Germany. Analysis of 110 patients diagnosed in 1965–95 // Scand J Gastroenterol. 1997. Vol. 32. P. 52–57. 8. Корой П.В. Болезнь Уиппла // Вестник молодого ученого. 2017. №3(17). C. 36–40 [Koroj P.V. Bolezn Uippla//Vestnik molodogo uchenogo. 2017. № 3(17). P. 36–40. (in Russian)]. 9. Fénollar F. Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of Whipple disease: usefulness of saliva and stool specimens for first-line screening // Clin Infect Dis. 2008. Vol. 47. P. 659–667. 10. Fenollar F., Trani M., Davoust B. et al. Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates // J Infec Dis. 2008. Vol. 197(6). Р. 880–887. 11. Schöniger-Hekele M., Petermann D., Weber B. et al. Tropheryma Whippelii in the environement: survey of sewage plant influxes and sewage plant workers // Appl Environ Microbiol. 2007. Vol. 73. Р. 2033–2035. 12. Zinkernagel A. S. Marginal and subgingival plaque — a natural habitat of Tropheryma whipplei? // Infection. 2003. Vol. 31. P. 86–91. 13. Maiwald M., Schuhmacher F., Ditton H.J. et al. Environmental occurence of the Whipple’s disease bacterium (Tropheryma Whippelii) // Appl Environment microbiol. 1998. Vol. 64. Р. 760–762. 14. Keita A.K., Bassene H., Tall A. et al. Tropheryma whipplei: a common bacterium in rural Senegal // PLoS Negl Trop Dis. 2011. Vol. 5 (12). Р. 1403. 15. Raoult D., Fenollar F., Rolain J.M. et al. Tropheryma whipplei in children with gastroenteritis // Emerg Infect Dis. 2010. Vol. 16. P. 776–782. 16. Keita A.K., Dubot-Peres A., Phommasone K. et al. High prevalence of Tropheryma whipplei in Lao kindergarten children // PLoS Negl Trop Dis. 2015. Vol. 9 (10). P. 1371. 17. Textbook of Gastroenterology, 5th edition / Fantry G.T., Fantry L.E., James S.P., Yamada T. Chichester. UK: Willey- Blackwell. 2009. P. 1225–1244. 18. Raoult D., Birg M.L., La Scola B. et al. Cultivation of the bacillus of Whipple’s disease // N Engl J Med. 2000. Vol. 342. P. 620–625. 19. La Scola B., Fenollar F., Perreal C., Raoult D. Epidemiologic implications of the first isolation and cultivation of Tropheryma whipplei from a saliva sample // Ann Intern Med. 2011. Vol. 154. P. 443–444. 20. Fenollar F., Ponge T., La Scola B. et al. First isolation of Tropheryma whipplei from bronchoalveolar fluid and clinical implications // J Infect. 2012. Vol. 65. P. 275–278. 21. Dutly F., Altwegg M. Whipple’s disease and «Tropheryma whippelii» // Clin Microbiol Rev. 2001. Vol. 14. P. 561–583. 22. Desnues B., Ihrig M., RaoultD. Mege J.-L. Whipple’s Disease: a Macrophage // Disease Clin Vaccine Immunol. 2006. Vol. 13(2). P. 170–178. 23. Peters S.E., Paterson G.K., Bandularatne E.S. et al. Salmonella enterica serovar typhimurium trxA mutants are protective against virulent challenge and induce less inflammation than the live-attenuated vaccine strain SL3261 // Infect Immun. 2010. Vol. 78. P. 326–336. 24. Ruben A., Dolmans V., Boel C.H.E. et al. Clinical manifestations, treatment, and diagnosis of Tropheryma whipplei infections // Clin Microbiol Rev. 2017. Vol. 30. P. 529–555. 25. Moos V., Schmidt C., Geelhaar A. et al. Impaired immune functions of monocytes and macrophages in Whipple’s disease // Gastroenterology. 2010. Vol. 138. P. 210–220. 26. Fenollar F., Amphoux B., Raoult D. A paradoxical Tropheryma whipplei Western blot differentiates patients with Whipple disease from asymptomatic carriers // Clin Infect Dis. 2009. Vol. 49. P. 717–723. 27. Maresi E., Argo A., Portelli F. et al. Rare occurrence of Whipple Disease in a young female patient with a fatal outcome // J Forensic Sci. 2013. Vol. 3(3). P. 85–91. 28. Lagier J.C., Lepidi H., Raoult D., Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center // Medicine (Baltimore). 2010. Vol. 89 (5). Р. 337–334. 29. Fenollar, F., Lagier J., Raoult D. Tropheryma whipplei and Whipple’s disease // J Infection. 2014. Vol. 69. Р. 103–112. 30. Bureš J., Kopáčová М., Douda T. et al. Whipple’s Disease: Our Own Experience and Review of the Literatura // Gastroenterol Res Pract. 2013. Article ID 478349. doi: 10.1155/2013/478349. 31. Маев И.В., Жиляев Е.В., Дичива Д.Т. и др. Болезнь Уиппла // Рос. журн. гастроэнтерол. гепатол. колопроктол. 2008. №5. С. 80–85 [Maev I.V., ZHilyaev E.V., Dichiva D.T. i dr. Bolezn’ Uippla // Ross. zhurn. gastroehnterol. gepatol. koloproktol. 2008. №5. P. 80–85 (in Russian)]. 32. Крумс А.М., Сабельникова Е.А., Голованова Е.В. и др. Болезнь Уиппла у больного детским церебральным параличом и циррозом печени В-вирусной этиологии // Тер. архив. 2014. №2. С. 69–71 [Krums A.M., Sabel’nikova E.A., Golovanova E.V. i dr. Bolezn’ Uippla u bol’nogo detskim cerebral’nym paralichom i cirrozom pecheni V-virusnoj ehtiologii // Ter. arhiv. 2014. №2. P. 69–71 (in Russian)]. 33. Дорофеев А. Болезнь Уиппла: клиника, диагностика, лечение // Новости медицины и фармации. Гастроэнтерология. 2011. №358. С. 3–4 [Dorofeev A.EH. Bolezn’ Uippla: klinika, diagnostika, lechenie // Novosti mediciny i farmacii. Gastroehnterologiya. 2011. №358. P. 3–471 (in Russian)]. 34. Ягур В.Е. Болезнь Уиппла // Медицинский журнал. 2016. №1. С. 76–81 [Yagur V.E. Bolezn’ Uippla // Medicinskij zhurnal. 2016. №1. P. 76–81 (in Russian)]. 35. Белов Б.С. Болезнь Уиппла // РМЖ. 2014. №28. С. 2063 [Belov B.S. Bolezn’ Uippla // RMJ. 2014. №28. P. 2063. (in Russian)]. 36. Fenollar F., Keita A.K., Buffet S., Raoult D. Intrafamilial circulation of Tropheryma whipplei, France // Emerg Infect Dis. 2012. Vol. 18. P. 949–955. 37. Moos V., Schneider T. Changing paradigms in Whipple’s disease and infection with Tropheryma whipplei // Eur J Clin Microbiol Infect Dis. 2011. Vol. 30. P. 1151–1158. 38. Fenollar F., Mediannikov O., Socolovschi C. Tropheryma whipplei bacteremia during fever in rural West Africa // Clin Infect Dis. 2010. Vol. 51. P. 515–521. 39. Lagier J.C., Fenollar F., Raoult D. Whipple’s disease and Tropheryma whipplei infections in internal medicine. When to think about it? How to treat? // Rev Med Interne. 2014. Vol. 35. P. 801–807. 40. Marth T. Systematic review: Whipple’s disease (Tropheryma whipplei infection) and its unmasking by tumour necrosis factor inhibitors // Aliment Pharmacol Ther. 2015. Vol. 41(8). P. 709–724. 41. Puechal X. Whipple disease and arthritis // Curr Opin Rheumatol. 2001. Vol. 13. P. 74–79. 42. Krol C.G., de Meijer P.H. Palindromic rheumatism: consider Whipple’s disease // Int J Rheum Dis. 2013. Vol. 16. P. 475–476. 43. Mahnel R., Kalt A., Ring S. et al. Immunosuppressive therapy in Whipple’s disease patients is associated with the appearance of gastrointestinal manifestations // Am J Gastroenterol 2005. Vol. 100. P. 1167–1173. 44. Whipple’s disease / Dobbins W.O. Springfield, IL. 1987. 242 p. 45. Schwartzman S., Schwartzman M. Whipple’s disease // Rheum Dis Clin North Am. 2013. Vol. 39. P. 313–321. 46. Love S.M., Morrison L., Appleby C., Modi P. Tropheryma whipplei endocarditis without gastrointestinal involvement // Interact Cardiovasc Thorac Surg. 2012. Vol. 15. P. 161–163. 47. Rusina R., Keller O., Sima R., Zamecnik J. Peripheral neuropathy in Whipples disease: a case report // Cesk Patol. 2012. Vol. 48. P. 97–99. 48. Gran J.T., Husby G. Joint manifestations in gastrointestinal diseases. 2. Whipple’s disease, enteric infections, intestinal bypass operations, gluten-sensitive enteropathy, pseudomembranous colitis and collagenous colitis // Dig Dis. 1992. Vol. 10. P. 295–312. 49. Smyth C., Kelleher D., Keeling P.W. Hepatic manifestations of gastrointestinal diseases: inflammatory bowel disease, celiac disease, and Whipple’s disease // Clin Liver Dis. 2002. Vol. 6. P. 1013–1032. 50. Marcial M.A., Villafaña M. Whipple’s disease with esophageal and colonic involvement: endoscopic and histopathologic findings // Gastrointestinal Endoscopy. 1997. Vol. 46(3). P. 263–266. 51. Klochan С., Anderson T. A., Rose D. et al. Nearly Fatal Case of Whipple’s Disease in a Patient Mistakenly on Anti-TNF TherapyACG // Case Rep J. 2013. Vol. 1(1). P. 25–28. 52. Black D.F., Aksamit A.J., Morris J.M. MR imaging of central nervous system Whipple disease: a 15-year review // AJNR Am J Neuroradiol. 2010. Vol. 31. P. 1493–1497. 53. Compain C., Sacre K., Puechal X. et al. Central nervous system involvement in Whipple disease: clinical study of 18 patients and long-term follow-up // Medicine (Baltimore). 2013. Vol. 92. P. 324–330. 54. Louis E.D., Lynch T., Kaufmann P. et al. Diagnostic guidelines in central nervous system Whipple’s disease // Ann Neurol. 1996. Vol. 40. P. 561–568. 54. Panegyres P.K. Diagnosis and management of Whipple’s disease of the brain // Pract Neurol. 2008. Vol. 8. P. 311–317. 55. Black D.F., Aksamit A.J., Morris J.M. MR imaging of central nervous system Whipple disease: a 15-year review // AJNR Am J Neuroradiol. 2010. Vol. 31. P. 1493–1497. 56. Enzinger F.M., Helwig E.B. Whipple’s disease: a review of the literature and report fifteen patients // Virchows Arch Pathol Anat Physiol Klin Med. 1963. Vol. 336. P. 238–269. 57. Geissdorfer W., Moos V., Moter A. et al. High frequency of Tropheryma whipplei in culture-negative endocarditis // J Clin Microbiol. 2012. Vol. 50. P. 216–222. 58. Fenollar F., Célard M., Lagier J.C. et al. Tropheryma whipplei endocarditis // Emerg Infect Dis. 2013. Vol. 19 (11). Р. 1721–1730. 59. Stojan G., Melia M.T., Khandhar S.J. et al. Constrictive pleuropericarditis: a dominant clinical manifestation in Whipple’s disease // BMC Infect Dis. 2013. Vol. 13. P. 579. 60. Urbanski G., Rivereau P., Artru L. et al. Whipple disease revealed by lung involvement: a case report and literature review // Chest. 2012. Vol. 141. P. 1595–1598. 61. Baloira A., Nunez M., Tumbeiro M. et al. Pulmonary hypertension associated with Whipple disease // Eur Respir Rev. 2014. Vol. 23. P. 533–536. 62. Friedmann A.C., Perera G.K., Jayaprakasam A. et al. Whipple’s disease presenting with symmetrical panniculitis // Br J Dermatol. 2004. Vol. 151. P. 907–911. 63. Paul J., Schaller J., Rohwedder A., Carlson J.A. Treated Whipple disease with erythema nodosum leprosum-like lesions: cutaneous PAS-positive macrophages slowly decrease with time and are associated with lymphangiectases: a case report // Am J Dermatopathol. 2012. Vol. 34. P. 182–187. 64. Alzahrani A.S., Al Sheef M. Severe primary hyperparathyroidism masked by asymptomatic celiac disease // Endocrine Practice. 2008. Vol. 14(3). P. 347–350. 65. Mori K., Ando I., Kukita A. Generalized hyperpigmentation of the skin due to vitamin B12 deficiency // Journal of Dermatology. 2001. Vol. 28(5). P. 282–285. 66. Drancourt M., Raoult D., Lepidi H. et al. Culture of Tropheryma whippelii from the vitreous fluid of a patient presenting with unilateral uveitis // Ann Intern Med. 2003. Vol. 139. P. 1046–1047. 67. Loughran D., Beale L., Lodge F. et al. Whipple’s in the valleys: a case of Whipple’s with thrombocytopenia and endocarditis // J Clin Pathol. 2014. Vol. 67. P. 445–448. 68. Edouard S., Fenollar F., Raoult D. The rise of Tropheryma whipplei: a 12-year retrospective study of PCR diagnoses in our reference center // J Clin Microbiol. 2012. Vol. 50(12). P. 3917–3920. 69. Edouard S., Fenollar F., Raoult D. The Rise of Tropheryma whipplei: a 12-Year Retrospective Study of PCR Diagnoses in Our Reference Center //J. Clin. Microbiol. 2012. Vol. 50(12). P. 3917–3920. 70. Chizinga M., Schiliro D., Mullin B., Barrie R. Mesenteric lymphadenitis as a presenting feature of Whipple’s disease // IDCases. 2017. Vol. 9. P. 50–52. 71. Gornals J.B., Baixeras N., Pales M.J. et al. Diagnosis of Whipple’s disease by EUS-guided-FNA and endoscopic biopsy at the same procedure // Gastrointestinal Endoscopy. 2012. Vol. 75(4). P. 895–896. 72. Lepidi H., Costedoat N., Piette J.C. et al. Immunohistological detection of Tropheryma whipplei (Whipple bacillus) in lymph nodes // Am J Med. 2002. Vol. 113. P. 334–336. 73. Boulos A., Rolain J-M., Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells // Antimicrobial Agents and Chemotherapy. 2004. Vol. 48(3). P. 747–752. 74. Keinath R.D., Merrell D.E., Vlietstra R., Dobbins W.O. Antibiotic treatment and relapse in Whipple’s disease: long term follow-up of 88 patients // Gastroenterology. 1985. Vol. 88. P. 1867–1873. 75. Feurle G.E., Junga N.S., Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple’s disease // Gastroenterology. 2010. Vol. 138(2). P. 478–486. 76. Apstein M.D., Schneider T. Whipple’s disease. UpToDate. [Электронный ресурс] //Wolters Kluwer, Waltham, MA. 2016. URL: http://www.uptodate.com/contents/whipples-disease. 77. Feurle G.E., Moos V., Bläker H. et al. Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple’s disease // Journal of Infection. 2013. Vol. 66(3). P. 263–270. 78. Lagier J.C., Fenollar F., Lepidi H. et al. Treatment of classic Whipple’s disease: from in vitro results to clinical outcome // J Antimicrob Chemother. 2014. Vol. 69. P. 219–227. 79. Меликян А.Л., Ковригина А.М., Никитин Е.А. Клин. рекоменд. по диагностике лимфаденопатий. М. 2014. 38 с. [Melikyan A.L., Kovrigina A.M., Nikitin E.A. Klin. rekomend. po diagnostike limfadenopatij. M. 2014. 38 р. (in Russian)].